Skip to main content
. Author manuscript; available in PMC: 2016 Jan 9.
Published in final edited form as: Vaccine. 2014 Dec 2;33(3):417–421. doi: 10.1016/j.vaccine.2014.11.036

Figure 1. Endpoint and toxin-neutralizing serum antibody titers elicited in mice following RiVax, DNI, and dual immunized mice.

Figure 1

Mice were immunized with RiVax, DNI, or the combination of RiVax and DNI adsorbed to aluminum salts on days 0 and 20, as noted in the text. Sera were collected on days 20 and 200 and examined for (A) ricin- and PA-specific IgG antibodies and (B) ricin and LT toxin-neutralizing activities. Symbols and error bars represent means and standard deviations.